The Advantage of Total Thyroidectomy to Avoid Reoperation for Incidental Thyroid Cancer in Multinodular Goiter

Archives of Surgery

Volumn 139, Issue 2, 2004, Pages 179-182

  Giles, Yasemin ^a   Boztepe, Harika ^a   Terzioǧlu, Tarik ^a   Tezelman, Serdar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HYPOPARATHYROIDISM; INCIDENTAL FINDING; MALE; NODULAR GOITER; PAPILLARY CARCINOMA; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; THYROID CANCER; THYROIDECTOMY; VOCAL CORD PARALYSIS;

ADULT; AGE FACTORS; BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; REOPERATION; RISK ASSESSMENT; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0842309826     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.2.179     Document Type: Article

References (49)

1. Siragusa G, Lanzara P, Di Pace G. Subtotal thyroidectomy or total thyroidectomy in the treatment of benign thyroid disease: our experience [in Italian]. Minerva Chir. 1998;53:233-238
2. Zaraca F, Di Paola M, Gossetti F, et al. Benign thyroid disease: 20-year experience in surgical therapy [in Italian]. Chir Ital. 2000;52:41-47.
3. Visset J, Lumingu K, Le Bodic MF, Paineau J, Letessier E. Total thyroidectomy to prevent recurrence of benign thyroid goiter [in French]. Chirurgie. 1991;117: 37-40.
4. Peix JL, Van Box Som P. Role of total thyroidectomy in the treatment of benign thyroid diseases [in French]. Ann Endocrinol (Paris). 1996;57:502-507.
5. Reeve TS, Delbribge L, Cohen A, Crummer P. Total thyroidectomy: the preferred option for multinodular goiter. Ann Surg. 1987;206:782-786.
6. Delbridge L, Guinea AI, Reeve TS. Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg. 1999;134:1389-1393.
7. Jacobs JK, Aland JW Jr, Ballinger JF. Total thyroidectomy: a review of 213 patients. Ann Surg, 1983;197:542-549.
8. Pappalardo G, Guadalaxara A, Frattaroli FM, Illomei G, Falaschi P. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg. 1998;164:501-506.
9. Liu O, Djuricin G, Prinz RA. Total thyroidectomy for benign thyroid disease, Surgery. 1998;123:2-7.
10. Mishra A, Agarwal A, Agarwal G, Mishra SK. Total thyroidectomy in benign thyroid disorders in an endemic region. World J Surg. 2001;25:307-310.
11. Gough IR, Wilkinson D. Total thyroidectomy for management of thyroid disease. World J Surg. 2000;24:962-965.
12. Berglund J, Bondesson L, Christensen SB, Larsson AS, Tibblin S. Indications for thyroxine therapy after surgery for nontoxic benign goitre. Acta Chir Scand. 1990;156:433-438.
13. Rojdmark J, Jarhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg. 1995;161:725-727.
14. Geerdsen JP, Frolund L. Thyroid function after surgical treatment of nontoxic goitre: a randomized study of postoperative thyroxine administration. Acta Med Scand. 1986;220:341-345.
15. Geerdsen JP, Frolund L. Recurrence of nontoxic goitre with and without post-operative thyroxine medication. Clin Endocrinol (Oxf). 1984;21:529-533.
16. Reeve TS, Delbridge L, Brady P, Crummer P, Smyth C, Secondary thyroidectomy: a twenty-year experience. World J Surg. 1988;12:449-453.
17. Pezzullo L, Delrio P, Losito NS, Caraco C, Mozzillo N. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer. Eur J Surg Oncol. 1997;23:215-218.
18. Bergamaschi R, Becouarn G, Ronceray J, Arnaud JP. Morbidity of thyroid surgery. Am J Surg. 1998;176:71-75.
19. Wilson DB, Staren ED, Prinz RA. Thyroid reoperations: indications and risks. Am Surg. 1998;64:674-678.
20. Beahrs OH, Vandertoll DJ. Complications of secondary thyroidectomy. Surg Gynecol Obstet. 1963;117:535-539.
21. McCall A, Jarosz H, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery. 1986;100: 1128-1132.
22. Koh KBH, Chang KW. Carcinoma in multinodular goitre. Br J Surg. 1992;79:266-267.
23. Lopez LH, Herrera MF, Gamino R, et al. Surgical treatment of multinodular goiter at the Instituto Nacional de nutricion Salvador Zubiran [in Spanish]. Rev Invest Clin. 1997;49:105-109.
24. Chao TC, Jeng LB, Lin JD, Chen MF. Reoperative thyroid surgery. World J Surg. 1997;21:644-647.
25. Calabro S, Auguste LJ, Attie JN. Morbidity of completion thyroidectomy for initially misdiagnosed thyroid carcinoma. Head Neck Surg. 1988;10:235-238.
26. Sachmechi I, Miller E, Varatharajah R, et al. Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract. 2000;6:5-7.
27. Mato A, Gippini A, Peino R, Gayosso P, Uriel B. Differentiated carcinoma of the thyroid gland in an area of endemic goiter: clinical study and prognostic correlation [in Spanish]. An Med Interna. 1996;13:537-540.
28. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050-1058.
29. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy [published correction appears in Semin Oncoll 1988;15(3):x]. Semin Oncol. 1987;14:315-322.
30. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy [published correction appears in Semin Oncoll 1988;15(3):x]. Semin Oncol. 1987;14:315-322.
31. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658-661.
32. Baudin E, Travagli JP, Ropers J, et al. Microcarciroma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998;83:553-559.
33. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720.
34. Logue JP, Tsang RW, Brierley JD, Simpson WJ. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Br J Radiol. 1994;67:1127-1131.
35. Rodriguez-Cuevas S, Labastida-Almendaro S, Briceno-Ancona N, Gonzalez-Rodriguez D. Reintervention to complete the surgical treatment of thyroid cancer: indications and histopathological findings [in Spanish]. Gac Med Mex. 1998; 134:677-683.
36. Wax MK, Briant DR. Completion thyroidectomy in the management of well-differentiated thyroid carcinoma. Otolaryngol Head Neck Surg. 1992;107:63-68.
37. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid. 2001;11:877-881.
38. Sarda AK, Kapur MM. Thyroid carcinoma: a report of 206 cases from an area with endemic goitre. Acta Oncol. 1990;29:863-867.
39. Alzahrani AS, Mandil AL, Chaudhary MA, Ahmed M, Mohammed GE. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer. Surgery. 2002; 131:443-449.
40. Machens A, Hinze R, Lautenschlager C, Thomusch O, Dralle H. Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: prediction of extrathyroidal soft tissue infiltrates. Thyroid. 2001;11:381-384.
41. Menegaux F, Turpin G, Dahman M, et al. Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery. 1999; 126:479-483.
42. Anderson PE, Hurley PR, Rosswick P. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet. 1990;171:309-314.
43. Kraimps JL, Marechaud R, Gineste D, et al. Analysis and prevention of recurrent goiter. Surg Gynecol Obstet. 1993;176:319-322.
44. Piraneo S, Vitri P, Galimberti A, Salvaggio A, Bastagli A. Ultrasonographic surveillance after surgery for euthyroid goitre in patients treated or not with thyroxine. Eur J Surg. 1997;163:21-26.
45. Piraneo S, Vitri P, Galimberti A, Guzzetti S, Salvaggio A, Bastagl A. Recurrence of goiter after operation in euthyroid patients. Eur J Surg. 1994;160:351-356.
46. Zelmanovitz T, Zelmanovitz F, Genro S, Gus P, de Azevedo MJ, Gross JL. Analysis of the factors associated with the recurrence of postthyroidectomy goiter[in Portuguese]: Rev Assoc Med Bras. 1995;41:86-10.
47. Gould EA, Hirsch E, Brecher I. Complications arising in the course of thyroidectomy. Arch Surg. 1965;90:81-85.
48. Foster RS Jr. Morbidity and mortality after thryoidectomy. Surg Gynecol Obstet. 1978;146:423-429.
49. Thomusch O, Machens A, Sekulla C, et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg. 2000;24:1335-1341.